Mylan N.V. - Company & Market Research Reports

Mylan are one of the largest generics and specialty pharmaceutical companies in the world, manufacturing and marketing over 1,400 different products to retail, wholesale, government and institutional customers. Mylan's business headquarters are based in Canonsburg, Pennsylvania, United States.

Competitor Analysis: VEGF Antibodies – Bevacizumab and Ranibizumab Biosimilars and Biosuperiors - Product Thumbnail Image

Competitor Analysis: VEGF Antibodies – Bevacizumab and Ranibizumab Biosimilars and Biosuperiors

  • Report
  • 70 Pages
From
Global Co-promotion and Co-marketing Partnering Terms and Agreements in Pharma, Biotech & Diagnostics 2012-2018 - Product Thumbnail Image

Global Co-promotion and Co-marketing Partnering Terms and Agreements in Pharma, Biotech & Diagnostics 2012-2018

  • Report
  • 344 Pages
From
Humira Biosimilars Clinical Trial Insight - Product Thumbnail Image

Humira Biosimilars Clinical Trial Insight

  • Clinical Trials
  • 80 Pages
From
Global Licensing Partnering Terms & Agreements in Pharma, Biotech & Diagnostics 2012-2018 - Product Thumbnail Image

Global Licensing Partnering Terms & Agreements in Pharma, Biotech & Diagnostics 2012-2018

  • Report
  • 2500 Pages
From
Global Manufacturing and Supply Partnering Terms and Agreements in Pharma, Biotech and Diagnostics 2012-2018 - Product Thumbnail Image

Global Manufacturing and Supply Partnering Terms and Agreements in Pharma, Biotech and Diagnostics 2012-2018

  • Report
  • 1600 Pages
From
Herceptin (Trastuzumab) Biosimilar Clinical Trial Insight - Product Thumbnail Image

Herceptin (Trastuzumab) Biosimilar Clinical Trial Insight

  • Clinical Trials
  • 85 Pages
From
Global Option and Evaluation Partnership Terms and Agreements in Pharma, Biotech and Diagnostics 2012-2018 - Product Thumbnail Image

Global Option and Evaluation Partnership Terms and Agreements in Pharma, Biotech and Diagnostics 2012-2018

  • Report
  • 1000 Pages
From
Enbrel Biosimilars Clinical Trial & Opportunity Insight - Product Thumbnail Image

Enbrel Biosimilars Clinical Trial & Opportunity Insight

  • Report
  • 70 Pages
From
Global Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics 2012 to 2018 - Product Thumbnail Image

Global Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics 2012 to 2018

  • Report
  • 457 Pages
From
Global Asset Purchase Partnering Terms and Agreements in Pharma, Biotech and Diagnostics 2012 to 2018 - Product Thumbnail Image

Global Asset Purchase Partnering Terms and Agreements in Pharma, Biotech and Diagnostics 2012 to 2018

  • Report
  • 950 Pages
From
Global Collaborative R&D Partnering Terms and Agreements in Pharma, Biotech & Diagnostics 2012-2018 - Product Thumbnail Image

Global Collaborative R&D Partnering Terms and Agreements in Pharma, Biotech & Diagnostics 2012-2018

  • Report
  • 2000 Pages
From
The Future of the U.S. Biologics and Biosimilars Treatment Market for Psoriasis - Product Thumbnail Image

The Future of the U.S. Biologics and Biosimilars Treatment Market for Psoriasis

  • Report
  • 104 Pages
From
Global Discovery Stage Partnering Terms and Agreements in Pharma and Biotech 2012- 2018 - Product Thumbnail Image

Global Discovery Stage Partnering Terms and Agreements in Pharma and Biotech 2012- 2018

  • Report
  • 1000 Pages
From
Global Distribution Partnering Terms and Agreements in Pharma, Biotech and Diagnostics 2012 to 2018 - Product Thumbnail Image

Global Distribution Partnering Terms and Agreements in Pharma, Biotech and Diagnostics 2012 to 2018

  • Report
  • 1500 Pages
From
Subcutaneous Biologics, Technologies and Drug Delivery Systems (2nd Edition), 2018-2030 - Product Thumbnail Image

Subcutaneous Biologics, Technologies and Drug Delivery Systems (2nd Edition), 2018-2030

  • Report
  • 350 Pages
From
Global Royalty Rate Trends in Pharma and Biotech Dealmaking 2010-2018 - Product Thumbnail Image

Global Royalty Rate Trends in Pharma and Biotech Dealmaking 2010-2018

  • Report
  • 350 Pages
From
 What's Trending in Monoclonal Antibodies (Market by Structure [Chimeric, Humanized], by Target [EGFR, TNF, HER2, CD20,PD-1, Other] and by Disease [Autoimmune, Oncology, Neurological, Other]) - Product Thumbnail Image

What's Trending in Monoclonal Antibodies (Market by Structure [Chimeric, Humanized], by Target [EGFR, TNF, HER2, CD20,PD-1, Other] and by Disease [Autoimmune, Oncology, Neurological, Other])

  • Report
  • 203 Pages
From
U.S. Specialty Injectable Generics Market Analysis By Therapeutic Use (Oncology, Cardiovascular, Central Nervous System, Infectious Diseases, Autoimmune Disorders), And Segment Forecasts, 2014 - 2025 - Product Thumbnail Image

U.S. Specialty Injectable Generics Market Analysis By Therapeutic Use (Oncology, Cardiovascular, Central Nervous System, Infectious Diseases, Autoimmune Disorders), And Segment Forecasts, 2014 - 2025

  • Report
  • 76 Pages
From
Generic Drugs Market: Global Industry Trends, Manufacturing Process, Share, Size, Growth, Opportunity and Forecast 2018-2023 - Product Thumbnail Image

Generic Drugs Market: Global Industry Trends, Manufacturing Process, Share, Size, Growth, Opportunity and Forecast 2018-2023

  • Report
  • 82 Pages
From
Adalimumab Market Analysis: by Applications and Geography - Forecast 2016-2021 - Product Thumbnail Image

Adalimumab Market Analysis: by Applications and Geography - Forecast 2016-2021

  • Report
  • 166 Pages
From
Loading Indicator
adroll